RA
Rushiraj Atulbhai Pandya
About Rushiraj Atulbhai Pandya
Data last updated:
Rushiraj Atulbhai Pandya is an Additional Director at Pan Drugs Limited (since 2025). The company operates in Pharma. Pan Drugs Limited reported revenue of ₹1.12 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Pan Drugs Limited U24230GJ1993PLC020671 | Additional Director | 10 Mar 2025 | 1993 | ₹1.12 Cr (FY 2025) | Active |
Board colleagues of Rushiraj Atulbhai Pandya
| Name | DIN | Company | Designation |
|---|---|---|---|
| Atul Natwarlal Pandya | 01687035 | Pan Drugs Limited | Director |
| Hemant Gajanand Upadhyay | 02907846 | Pan Drugs Limited | Director |
| Kamal Natwarlal Pandya | 01679134 | Pan Drugs Limited | Director |
| Parag Vamanray Raval | 00533939 | Pan Drugs Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rushiraj Atulbhai Pandya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rushiraj Atulbhai Pandya
Rushiraj Atulbhai Pandya currently holds 1 directorship: Pan Drugs Limited (Additional Director, since 10 Mar 2025, revenue ₹1.12 Cr (FY 2025)).
Rushiraj Atulbhai Pandya was first appointed on 10 Mar 2025 as Additional Director at Pan Drugs Limited.
The current boards of Rushiraj Atulbhai Pandya's companies include Atul Natwarlal Pandya (Pan Drugs Limited), Hemant Gajanand Upadhyay (Pan Drugs Limited), Kamal Natwarlal Pandya (Pan Drugs Limited), Parag Vamanray Raval (Pan Drugs Limited).